Web-Books
in the Austria-Forum
Austria-Forum
Web-Books
Medizin
Advances in Neuroimmunology
Page - 62 -
  • User
  • Version
    • full version
    • text only version
  • Language
    • Deutsch - German
    • English

Page - 62 - in Advances in Neuroimmunology

Image of the Page - 62 -

Image of the Page - 62 - in Advances in Neuroimmunology

Text of the Page - 62 -

BrainSci. 2016,6, 41 45. Nash, K.R.; Lee, D.C.; Hunt, J.B.; Morganti, J.M.; Selenica,M.-L.L.; Moran, P.; Reid, P.; Brownlow,M.; Yang,C.G.; Savalia,M.; et al. Fractalkineoverexpressionsuppresses taupathology inamousemodelof tauopathy.Neurobiol. Aging2013,34, 1540–1548. [CrossRef] [PubMed] 46. Lee, S.; Xu,G.; Jay, T.R.; Bhatta, S.; Kim,K.-W.W.; Jung, S.; Landreth,G.E.; Ransohoff, R.M.; Lamb,B.T. Opposing effects ofmembrane-anchoredCX3CL1 on amyloid and tau pathologies via the p38MAPK pathway. J.Neurosci. 2014,34, 12538–12546. [CrossRef] [PubMed] 47. Norden,D.M.;Godbout, J.P.Review:Microgliaof theagedbrain: Primedtobeactivatedandresistant to regulation.Neuropathol. Appl.Neurobiol. 2013,39, 19–34. [CrossRef] [PubMed] 48. Bachstetter,A.D.;Morganti, J.M.; Jernberg, J.; Schlunk,A.;Mitchell, S.H.; Brewster,K.W.;Hudson,C.E.; Cole,M.J.;Harrison, J.K.;Bickford,P.C.; etal. FractalkineandCX3CR1regulatehippocampalneurogenesis inadultandagedrats.Neurobiol. Aging2011,32, 2030–2044. [CrossRef] [PubMed] 49. Wynne,A.M.;Henry,C.J.; Huang,Y.; Cleland,A.; Godbout, J.P. ProtracteddownregulationofCX3CR1 onmicroglia of agedmice after lipopolysaccharide challenge. BrainBehav. Immun. 2010, 24, 1190–1201. [CrossRef] [PubMed] 50. Surmeier,D.J.;Guzman, J.N.;Sanchez-Padilla, J.Calcium,cellularaging,andselectiveneuronalvulnerability inParkinson’sdisease.CellCalcium2010,47, 175–182. [CrossRef] [PubMed] 51. Surmeier,D.;Guzman, J.; Sanchez-Padilla, J.;Goldberg, J.Whatcauses thedeathofdopaminergicneurons inParkinson’sDisease?Prog. BrainRes. 2010,183, 59–77. [PubMed] 52. Kim,Y.H.;Koh,H.-K.K.;Kim,D.-S.S.Down-regulationof IL-6productionbyastaxanthinviaERK-,MSK-, andNF-ĪŗB-mediatedsignals inactivatedmicroglia. Int. Immunopharmacol. 2010,10, 1560–1572. [CrossRef] [PubMed] 53. Liu,X.; Shibata,T.;Hisaka, S.;Osawa,T.Astaxanthin inhibits reactiveoxygenspecies-mediatedcellular toxicity indopaminergicSH-SY5Ycellsviamitochondria-targetedprotectivemechanism.BrainRes. 2009, 1254, 18–27. [CrossRef] [PubMed] 54. Lee,D.-H.H.; Kim,C.-S.S.; Lee, Y.J. Astaxanthin protects againstMPTP/MPP+-inducedmitochondrial dysfunctionandROSproduction invivoand invitro. FoodChem. Toxicol. 2011, 49, 271–280. [CrossRef] [PubMed] 55. Kidd, P. Astaxanthin, a cellmembrane nutrientwith diverse clinical benefits and anti aging potential. Am.Med.Rev. 2011,16, 355–364. 56. Park, J.;Mathison,B.;Hayek,M.;Zhang, J.;Reinhart,G.;Chew,B.Astaxanthinmodulatesage-associated mitochondrialdysfunction inhealthydogs. J.Anim. Sci. 2012,91, 268275. [CrossRef] [PubMed] 57. Otton,R.;Marin,D.P.;Bolin,A.P.;Santos,R.C.;Polotow,T.G.;Sampaio,S.C.;deBarros,M.P.Astaxanthin ameliorates theredox imbalance in lymphocytesofexperimentaldiabetic rats.Chem. Biol. Interact. 2010,186, 306–315. [CrossRef] [PubMed] 58. Augusti, P.R.; Quatrin, A.; Somacal, S.; Conterato, G.M.; Sobieski, R.; Ruviaro, A.R.; Maurer, L.H.; Duarte,M.M.; Roehrs,M.; Emanuelli, T. Astaxanthin prevents changes in the activities of thioredoxin reductaseandparaoxonaseinhypercholesterolemicrabbits. J.Clin. Biochem.Nutr.2012,51, 42–49. [CrossRef] [PubMed] 59. Li,Z.;Dong,X.;Liu,H.;Chen,X.;Shi,H.;Fan,Y.;Hou,D.;Zhang,X.AstaxanthinprotectsARPE-19cells fromoxidativestressviaupregulationofNrf2-regulatedphase IIenzymesthroughactivationofPI3K/Akt. Mol.Vis. 2013,19, 1656–1666. [PubMed] 60. Wang,H.-Q.Q.;Sun,X.-B.B.;Xu,Y.-X.X.;Zhao,H.;Zhu,Q.-Y.Y.;Zhu,C.-Q.Q.Astaxanthinupregulatesheme oxygenase-1expressionthroughERK1/2pathwayanditsprotectiveeffectagainstbeta-amyloid-induced cytotoxicity inSH-SY5Ycells.BrainRes. 2010,1360, 159–167. [CrossRef] [PubMed] 61. Brunk,U.T.; Terman,A. Themitochondrial-lysosomal axis theory of aging: Accumulation of damaged mitochondriaasaresultof imperfectautophagocytosis.Eur. J.Biochem. 2002,269, 1996–2002. [CrossRef] [PubMed] 62. Collier,T.J.;Kanaan,N.M.;Kordower, J.H.Ageingasaprimaryrisk factor forParkinson’sdisease: Evidence fromstudiesofnon-humanprimates.Nat. Rev.Neurosci. 2011,12, 359–366. [CrossRef] [PubMed] 63. Qin,Y.; Sun,X.; Shao,X.;Cheng,C.;Feng, J.; Sun,W.;Gu,D.;Liu,W.;Xu,F.;Duan,Y.Macrophage-microglia networksdriveM1microgliapolarizationaftermycobacteriuminfection. Inflammation2015,38, 1609–1616. [CrossRef] [PubMed] 62
back to the  book Advances in Neuroimmunology"
Advances in Neuroimmunology
Title
Advances in Neuroimmunology
Author
Donna Gruol
Editor
MDPI
Location
Basel
Date
2017
Language
English
License
CC BY-NC-ND 4.0
ISBN
978-3-03842-571-7
Size
17.0 x 24.0 cm
Pages
164
Keywords
neuroimmune, cytokine, chemokine, glia cel, neuron, neurodevelopment, neuroimmune disorder, neurologic disease, psychiatric disease, neuronal injury
Category
Medizin
Web-Books
Library
Privacy
Imprint
Austria-Forum
Austria-Forum
Web-Books
Advances in Neuroimmunology